A new staging strategy for chronic obstructive pulmonary disease

International Journal of COPD

Volumn 2, Issue 4, 2007, Pages 657-663

  Miller, Martin R ^a,d   Pedersen, Ole F ^b   Dirksen, Asger ^c  

^a UNIVERSITY HOSPITALS BIRMINGHAM NHS FOUNDATION TRUST   (United Kingdom)

^b AARHUS UNIVERSITY   (Denmark)

^c Mental Health Services CPH   (Denmark)

^d UNIVERSITY DEPARTMENT OF MEDICINE   (United Kingdom)

Author keywords

Chronic obstructive pulmonary disease; Respiratory function tests; Spirometry

Indexed keywords

BRONCHODILATING AGENT; CORTICOSTEROID;

ADULT; AGE; AGED; ARTICLE; BODY HEIGHT; CHRONIC OBSTRUCTIVE LUNG DISEASE; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; FORCED EXPIRATORY VOLUME; HUMAN; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; PREDICTION; SEX DIFFERENCE; STAGING; SURVIVAL RATE; UNIVARIATE ANALYSIS;

AGED; DENMARK; FEMALE; FORCED EXPIRATORY VOLUME; HUMANS; MALE; MIDDLE AGED; MODELS, STATISTICAL; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; SEVERITY OF ILLNESS INDEX; SPIROMETRY;

EID: 38049121623     PISSN: 11769106     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. [ATS] American Thoracic Society. 1987. Standardization of spirometry: 1987 update. Am Rev Respir Dis, 136:1286-96.
2. [ATS] American Thoracic Society. 1995. Standardization of spirometry. 1994 update. Am J Respir Crit Care Med, 152:1107-36.
3. [ATS] American Thoracic Society. 1995. COPD Guidelines. Am J Respir Crit Care Med, 152:S77-S120.
4. Ashley F, Kannel WB, Sorlie PD, et al. 1975. Pulmonary function: relation to aging, cigarette habit, and mortality. The Framingham Study. Ann Intern Med, 82:739-45.
5. British Guideline. 2003. British guideline on the management of asthma. Thorax, 58:Suppl 1.
6. Burrows B, Earle RH. 1969. Course and prognosis of chronic obstructive lung disease. A prospective study of 200 patients. N Engl J Med, 280:397-404.
7. Burrows B, Earle RH. 1969. Prediction of survival in patients with chronic airway obstruction. Am Rev Respir Dis, 99:865-71.
8. Celli BR, Cote CG, Marin JM, et al. 2004. The body-mass index, airflow obstruction, dyspnea, and exercise capacity index in chronic obstructive pulmonary disease. N Engl J Med, 350:1005-12.
9. Chinn S, Gislason C, Aspefund T, et aL 2007. Optimum expression of adult lung function based on all-cause mortality: results from the Reykjavik study. Respir Med, 101:601-9.
10. Cox DR. 1972. Regression models and life tables. J Royal Stat Soc, B34:187-220.
11. Gorecka D, Gorzelak K, Sliwinski P, et al. 1997. Effect of long term oxygen therapy on survival in patients with chronic obstructive pulmonary disease with moderate hypoxaemia. Thorax, 52:667-8.
12. Hansen EF, Phanareth K, Laursen LC, et al. 1999. Reversible and irreversible airflow obstruction as predictor of overall mortality in asthma and chronic obstructive pulmonary disease. Am J Respir Crit Care Med, 159:1267-71.
13. Hansen EF, Vestbo J, Phanareth K, et al. 2001. Peak flow as predictor of overall mortality in asthma and chronic obstructive pulmonary disease. Am J Respir Crit Care Med, 163:690-3.
14. Kerstjens HAM. 2004. The GOLD classification has not advanced understanding of COPD. Am J Respir Crit Care Med, 170:212-13.
15. Knuiman MW, James AL, Divitini ML, et al. 1999. Lung function, respiratory symptoms, and mortality: results from the Busselton Health Study. Ann Epidemiol, 9:297-306.
16. Lange P, Nyboe J, Appleyard M, et al. 1990. Spirometric findings and mortality in never-smokers. J Clin Epidemiol, 43:867-73.
17. Miller MR, Pincock AC, Grove DM. 1985. Patterns of spirogram abnormality in individual smokers. Am Rev Respir Dis, 132:1034-40.
18. Miller MR, Pincock AC. 1988. Predicted values: how should we use them? Thorax, 43:265-7.
19. [NIH] National Institutes of Health, National Heart, Lung and Blood Institute, 2005. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. NHLBI/WHO Workshop Report. Update 2005 [online]. Accessed on May 22, 2007. URL: http://www.goldcopd.com
20. Quarjer PhH,Tammeling GJ, Cotes JE, et al. 1993. Standardized lung function testing. Lung volumes and forced ventilatory flows. Eur Respir J, 6, (Suppl 16):5-40.
21. Schunemann HJ, Dorn J, Grant BJ, et al. 2000. Pulmonary function is a long-term predictor of mortality in the general population: 29-year follow-up of the Buffalo Health Study. Chest, 118:656-64.
22. Siafakas NM, Vermeire P, Pride NB, et al. 1995. ERS - Consensus statement. Optimal assessment and management of chronic obstructive pulmonary disease (COPD). Eur Respir J, 8:13 98-420.
23. Sobol BJ, Weinheimer A. 1966. Assessment of ventilatory abnormality in the asymptomatic subject: an exercise in futility. Thorax, 21:445-9.
24. Sood N, Paradowski LJ, Yankaskas JR. 2001. Outcomes of intensive care unit care in adults with cystic fibrosis. Am J Respir Crit Care Med, 163:335-8.
25. Thomason MJ, Strachan DP. 2000. Which spirometric indices best predict subsequent death from chronic obstructive pulmonary disease? Thorax, 55:785-8.